Controlled Release Scaffolds for Nerve Regeneration
Controlled Release Scaffolds for Nerve Regeneration
批准号:
7753896
负责人:
Lonnie D Shea
金额:
$38.14万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-01-22 至 2010-12-31
关键词:
AffectAntigen-Presenting CellsAreaAxonBindingBiocompatibleBiocompatible MaterialsBrain-Derived Neurotrophic FactorCaliberCell CountCell DeathCell TransplantationCell TransplantsCellsChargeChondroitinasesCicatrixCoculture TechniquesCombined Modality TherapyDNADNA deliveryDemyelinationsDependenceDepositionDoseDrug Delivery SystemsEnsureEnvironmentEquilibriumFamily suidaeGene DeliveryGene TransferGlycolic-Lactic Acid PolyesterGoalsGrowthGrowth ConesHyaluronidaseIn VitroInjuryLocationModelingMolecular ProfilingMolecular WeightNatural regenerationNerve RegenerationNeuritesNeuronsOligodendrogliaParalysedPlasmidsPolymersPopulationProcessProductionPropertyProteinsPumpRelative (related person)Research PersonnelSignal TransductionSiteSpinal CordSpinal Cord TractStimulusSurfaceSystemTestingTimeTissue EngineeringTissuesTransfectionaxon growthbasecontrolled releasedesigndosageextracellularimplantationin vitro Modelin vivoinhibitor/antagonistinjuredneurotrophic factorpreventscaffoldspinal cord regenerationspinal cord repairtargeted deliverytraffickingtransgene expressionvector
中文摘要
描述(由申请人提供):脊髓损伤导致损伤水平以下的瘫痪,这是由细胞死亡和有限的再生引起的。尽管脊髓神经元具有先天的再生能力,但促进再生的因子供应不足,抑制再生的因子供应充足,限制了它们的再生能力。我们的长期目标是开发一种基于生物材料的联合疗法,通过桥接损伤部位来控制微环境。桥的微观结构将指导轴突的生长,而局部药物递送将提供刺激再生的因素,同时限制抑制轴突生长的因素。能够局部传递DMA的桥将局部转染细胞,而蛋白质传递将降解再生抑制剂。这种桥释放编码神经营养因子的DMA,将被用来验证这样的假设,即转染谱将启动轴突延伸到桥,穿过损伤部位,并促进重新进入宿主组织。这一假设基于以下观察:1)DMA递送可以诱导体内持续的、局部的转基因表达,2)神经营养因子递送到损伤部位可以促进轴突伸长形成合成桥,3)细胞移植或渗透泵植入不能提供可控制的神经营养因子浓度来促进再生。Iv)通过将桥内促进生长的刺激降低到与宿主组织相当的水平,以及桥附近疤痕中的降解抑制剂,可以促进轴突重新进入宿主。基于这些观察结果,实验的重点是设计有效的基因转移桥并将其应用于脊髓再生模型。特异性目的1:通过多通道桥的持续释放,研究转基因在脊髓中的表达(数量、持续时间)和转染(细胞数量、分布和身份)。具体目的2:研究轴突伸长与转染剖面使用体外模型。具体目的3:研究体内轴突通过桥的生长对转染剖面的依赖性,以最大限度地增加通过桥的轴突数量。特异性目标4:研究神经磷脂编码质粒和软骨素酶的双重递送,以使轴突通过桥,重新进入宿主组织,这是目标3的重点。
英文摘要
DESCRIPTION (provided by applicant): Injury to the spinal cord results in paralysis below the level of the injury, which results from cell death and limited regeneration. Although spinal cord neurons have the innate capacity to regenerate, they are limited by an insufficient supply of factors to promote regeneration, and an abundant supply of factors that inhibit regeneration. Our long-term goal is to develop a combination therapy based on biomaterials that bridge the injury site to control the microenvironment. The bridge microstructure will direct axonal outgrowth and localized drug delivery will provide factors that stimulate regeneration yet limit the factors that inhibit axonal outgrowth. Bridges capable of localized DMA delivery will transfect cells locally, whereas protein delivery will degrade inhibitors to regeneration. This bridge releasing DMA encoding for neurotrophic factors will be employed to test the hypothesis that the transfection profile will initiate axonal elongation into the bridge, across the injury site, and facilitate re-entry into the host tissue. This hypothesis is based on the observations that i) DMA delivery can induce sustained, localized transgene expression in vivo, ii) neurotrophin delivery to the injury site can promote axonal elongation into a synthetic bridge, iii) cell transplantation or osmotic pump implantation does not provide a controllable concentration of neurotrophins for promoting regeneration, iv) axonal re-entry into the host is encouraged by reducing the growth promoting stimuli within the bridge to levels comparable to host tissue, and degrading inhibitors in the scar adjacent to the bridge. Based on these observations, the experimental focus is on designing bridges for efficient gene transfer and applying them in a spinal cord model of regeneration. Specific Aim 1: Investigate transgene expression (quantity, duration) and transfection (cell number, distribution, and identity) in the spinal cord by sustained release from the multiple channel bridge. Specific Aim 2: Investigate axonal elongation with the transfection profile using an in vitro model. Specific Aim 3: Investigate the dependence of axonal growth through the bridge in vivo on the transfection profile to maximize the number of axons crossing the bridge. Specific Aim 4: Investigate dual delivery of neurorophin-encoding plasmid and chondroitinase to enable axons crossing the bridge, the focus of Aim 3, to re-enter the host tissue.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Scaffolds for culture and transplantation of islet organoids
-
批准号:10380872
-
项目类别:
-
资助金额:$55.07万
-
财政年份:2020
-
负责人:Lonnie D Shea
-
依托单位:
Scaffolds for culture and transplantation of islet organoids
-
批准号:10197921
-
项目类别:
-
资助金额:$55.07万
-
财政年份:2020
-
负责人:Lonnie D Shea
-
依托单位:
Scaffolds for culture and transplantation of islet organoids
-
批准号:9887396
-
项目类别:
-
资助金额:$55.07万
-
财政年份:2020
-
负责人:Lonnie D Shea
-
依托单位:
Microporous scaffolds for enhancing efficiency of beta-cell progenitor maturation in vitro and in vivo
-
批准号:9331833
-
项目类别:
-
资助金额:$21.92万
-
财政年份:2017
-
负责人:Lonnie D Shea
-
依托单位:
Integrated Structural BMP2 Carrier Systems for Cervical Spine Fusion
-
批准号:8720503
-
项目类别:
-
资助金额:$58.19万
-
财政年份:2011
-
负责人:Lonnie D Shea
-
依托单位:
Protein-Releasing Microporous Scaffolds for Cell Replacement Therapy
-
批准号:8977538
-
项目类别:
-
资助金额:$0.51万
-
财政年份:2010
-
负责人:Lonnie D Shea
-
依托单位:
Human islet transplantation on microporous scaffolds
-
批准号:7930629
-
项目类别:
-
资助金额:$18.29万
-
财政年份:2009
-
负责人:Lonnie D Shea
-
依托单位:
Human islet transplantation on microporous scaffolds
-
批准号:7789811
-
项目类别:
-
资助金额:$22.31万
-
财政年份:2009
-
负责人:Lonnie D Shea
-
依托单位:
Biotechnology Predoctoral Training Program
-
批准号:7883854
-
项目类别:
-
资助金额:$9.39万
-
财政年份:2009
-
负责人:Lonnie D Shea
-
依托单位:
Transfected cell arrays for cancer research
-
批准号:7192889
-
项目类别:
-
资助金额:$18.21万
-
财政年份:2007
-
负责人:Lonnie D Shea
-
依托单位:
P30A: Biomaterials Core (6 of 10)
-
批准号:7491495
-
项目类别:
-
资助金额:$43.75万
-
财政年份:2007
-
负责人:Lonnie D Shea
-
依托单位:
Controlled Release Scaffolds for Nerve Regeneration
-
批准号:7196025
-
项目类别:
-
资助金额:$33.79万
-
财政年份:2007
-
负责人:Lonnie D Shea
-
依托单位:
Transfected cell arrays for cancer research
-
批准号:7499610
-
项目类别:
-
资助金额:$14.57万
-
财政年份:2007
-
负责人:Lonnie D Shea
-
依托单位:
Parallel gene delivery from spinal cord bridges
-
批准号:7416586
-
项目类别:
-
资助金额:$17.36万
-
财政年份:2007
-
负责人:Lonnie D Shea
-
依托单位:
P30A: Biomaterials Core (6 of 10)
-
批准号:7921442
-
项目类别:
-
资助金额:$46.0万
-
财政年份:2007
-
负责人:Lonnie D Shea
-
依托单位:
P30A: Biomaterials Core (6 of 10)
-
批准号:8114123
-
项目类别:
-
资助金额:$46.77万
-
财政年份:2007
-
负责人:Lonnie D Shea
-
依托单位:
Biomaterials Core
-
批准号:7467564
-
项目类别:
-
资助金额:$43.28万
-
财政年份:2007
-
负责人:Lonnie D Shea
-
依托单位:
Parallel gene delivery from spinal cord bridges
-
批准号:7258135
-
项目类别:
-
资助金额:$20.98万
-
财政年份:2007
-
负责人:Lonnie D Shea
-
依托单位:
P30A: Biomaterials Core (6 of 10)
-
批准号:7645616
-
项目类别:
-
资助金额:$45.25万
-
财政年份:2007
-
负责人:Lonnie D Shea
-
依托单位:
Controlled Release Scaffolds for Nerve Regeneration
-
批准号:7342013
-
项目类别:
-
资助金额:$30.34万
-
财政年份:2007
-
负责人:Lonnie D Shea
-
依托单位:
海外基金